基酸激酶缺乏扩大了系统性自身炎症性疾病的遗传谱
Jakob Berner1, Cheryl van de Wetering2, Raul Jimenez Heredia3
1St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria; St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria; Department of Dermatology, Venereology and Allergology, Klinik Landstraße, Vienna, Austria.
The Journal of allergy and clinical immunology
|June 26, 2023
概括
研究人员确定了第一个患有基酸盐激酶 (PMVK) 缺乏症的患者,这是一种自身炎症性疾病. 这一发现扩大了这种疾病的已知遗传原因,并突出了差异诊断中的PMVK缺乏.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 甲酸激酶 (MVK) 和甲酸激酶 (PMVK) 是异oprenoid生物合成中的关键酶.
- MVK中的双性致病变体导致MVK缺乏,一种自身炎症性疾病.
- 之前没有报告有PMVK缺乏症的患者.
研究的目的:
- 报告第一个功能确认的PMVK缺陷病例.
- 详细说明同卵性PMVK变异的临床,生化和免疫后果.
- 研究PMVK缺乏对异oprenoid生物合成的影响.
主要方法:
- 在怀疑自身炎症性疾病的患者身上进行了全外测序.
- 在患者衍生细胞上进行了功能性研究.
- 用遗传算法和建模分析来评估变体的病原性.
主要成果:
- 在该患者身上发现了一种同卵性PMVK误解变体 (p.Val131Ala).
- 患者细胞显示PMVK酶活性和蛋白质水平显著降低.
- 该患者出现了与MVK缺乏症不同的自身炎症症状,并且对IL-1抑制有反应.
结论:
- 这项研究证实了第一个PMVK缺陷病例,这是由同卵性PMVK变种引起的自身炎症性疾病.
- 在系统性自身炎症性疾病的差异诊断中应考虑PMVK缺乏症.
- 这些发现扩大了自身炎症状况的遗传谱.
相关概念视频
Inborn Errors of Metabolism
206
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
206
Autoimmune Disorders
526
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
526
Rheumatic Heart Disease I: Introduction
17
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Phosphoinositides and PIPs
8.6K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K


